FDA Wants More Study for Diabetes Drugs to Better Asses for Heart Risks

More than a year after GlaxoSmithKline PLC’s Avandia was linked to higher risk of heart...

» read full story

December 18th, 2008 - 13:34

Study: Byetta Is Better Than Januvia At Lowering Glucose Levels

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced that a randomized, double-blind,...

» read full story

September 09th, 2008 - 20:43

FDA Seeks Pancreatitis Warning for Diabetes Drug Byetta

The Food and Drug Administration on Monday announced that it’s seeking a stronger, more prominent...

» read full story

August 19th, 2008 - 13:30

FDA Requires More Study Of Heart Risk For Diabetes Drugs

More than a year after GlaxoSmithKline PLC’s Avandia was linked to higher risk of heart...

» read full story

December 18th, 2008 - 20:21

Byetta Outruns Rival Januvia in Diabetes Trial

Eli Lilly and Co and Amylin Pharmaceuticals Inc’s diabetes drug Byetta proved better at reducing...

» read full story

September 10th, 2008 - 15:20

Amylin Shares Drop as FDA Warns about Byetta’s Pancreatitis Risk

The United States Food and Drug Administration issued Monday warnings to doctors and patients as...

» read full story

August 19th, 2008 - 15:49